BMO Capital lowered the firm’s price target on Genpact (G) to $48 from $49 and keeps a Market Perform rating on the shares. The company delivered a solid September quarter highlighted by exceeding the high-end of the revenue guidance range, margin expansion, and raised FY25 revenue guide, the analyst tells investors in a research note. Genpact shared that demand signals remain strong, including pipeline strength and agentic solution adoption, the firm added.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on G:
- Genpact’s Strong Q3 Performance and Strategic Growth in Advanced Technology Solutions Drive Optimistic Outlook and Buy Rating
- Genpact’s Strong Q3 Performance and AI Demand Drive Buy Rating
- Genpact’s Q3 2025 Earnings Show Robust Growth
- Genpact’s Strong Performance and Strategic Investments Justify Buy Rating with $55 Target
- Genpact reports Q3 adjusted EPS 97c, consensus 90c